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Background: Growing evidence indicates that intestinal microbiota regulate our metabolism. Probiotics confer
health benefits that may depend on their ability to affect the gut microbiota. The objective of this study was to
examine the effect of supplementation with the probiotic strain, Lactobacillus rhamnosus hsryfm 1301, on the gut
microbiota in a hyperlipidemic rat model, and to explore the associations between the gut microbiota and the
serum lipids.
Methods: The hyperlipidemic rat model was established by feeding rats a high-fat diet for 28 d. The rats’ gut microbiota
were analyzed using high-throughput sequencing before and after L. rhamnosus hsryfm 1301 supplementation or
its fermented milk for 28 d. The serum lipids level was also tested.
Results: The rats’ primary gut microbiota were composed of Bacteroidetes, Firmicutes, Proteobacteria, Spirochaetes
and Verrucomicrobia. The abundance and diversity of the gut microbiota generally decreased after feeding with a
high-fat diet, with a significant decrease in the relative abundance of Bacteroidetes, but with an increase in that of
Firmicutes (P < 0.05). Administration of L. rhamnosus hsryfm 1301 or its fermented milk for 28 d, could recover the
Bacteroidetes and Verrucomicrobia abundance and could decrease the Firmicutes abundance, which was associated
with a significant reduction in the serum lipids’ level in the hyperlipidemic rats with high-fat diet induced. The
abundance of 22 genera of gut bacteria was changed significantly after probiotic intervention for 28 d (P < 0.05). A
positive correlation was observed between Ruminococcus spp. and serum triglycerides, Dorea spp. and serum cholesterol
(TC) and low-density lipoprotein (LDL-C), and Enterococcus spp. and high-density lipoprotein. The Butyrivibrio spp.
negatively correlated with TC and LDL-C.
Conclusions: Our results suggest that the lipid metabolism of hyperlipidemic rats was improved by regulating the
gut microbiota with supplementation of L.rhamnosus hsryfm 1301 or its fermented milk for 28 d.Background
The total number of microbes in the adult gut is 1014,
which is 10-fold higher than the number of human body
cells [1]. It has been proposed that the capacity of the
microbiome largely exceeds the human genome with
more than three million genes [2], which are rich in
carbohydrates, amino acids, vitamins, and other genes* Correspondence: guruixia1963@163.com
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unless otherwise stated.involved in nutrient metabolism, most of which are absent
in humans [3]. The intestinal microbes affect our lives not
only through food metabolism and exclusion of pathogens,
but also by modulating the mucosal immune response [4].
Hence, they have a remarkable potential to influence the
physiological functions and health of the host [5,6].
Probiotics are defined as live micro-organisms that
confer health benefits to the gut microbiota of the host
when present in adequate amounts. The function of the
intestinal microbiota is not understood, yet. Nonetheless,
advances in culture-independent molecular techniques
have provided insight into the composition of the intes-
tinal microbiota before and after probiotic intake [7].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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primary risk factor for the development of atherosclerosis,
coronary heart disease and other cardiovascular diseases
[8]. Currently, drug therapy is the principal treatment, but
with high relative costs and side effects, it is not consid-
ered to be an optimal long-term treatment. Recent studies
have demonstrated that Lactobacilli or Bifidobacteria
could exhibit hypolipidemic effects in animal models
[9,10] and in humans [11,12]. Furthermore, the intestinal
microbiota could improve the host’s lipid metabolism via
microbial activities [13]. The widely accepted mechanism
is that microbiota activities promote bile acid biotrans-
formation in vivo to regulate fat digestion, and affect lipid
metabolism to decrease serum lipids [14].
In the present study, L. rhamnosus hsryfm 1301, which
is a strong hypolipidemic agent in vitro, was isolated
from the gut of subjects from Bama, Guangxi Province,
China, who are known for increased longevity. As dairy
products may be suitable vehicles for the delivery of pro-
biotics and may enhance the effect of products on the
host’s health, L. rhamnosus hsryfm
1301-containing skim milk suspension and its fermen-
ted milk were used to investigate the effect on serum
lipids and on the composition of the intestinal microbiota
in hyperlipidemic rats, and to explore the possible mech-
anism of hypolipidemic of lactic acid bacteria in vivo.Methods
Bacteria and culture
L. rhamnosus strain hsryfm 1301 was obtained from the
Key Lab of Dairy Biotechnology and Safety Control,
Yangzhou University, which was isolated from the gut of
subjects from Bama longevity, Guangxi Province, China,
in 2013. The bacteria were grown in MRS medium at
37°C in an anaerobic jar (Ruskinn Technologies, Ltd.,
South Wales, UK) for 24 h.
Cells were collected by centrifugation at 4,000 × g for
10 min at 4°C. The L. rhamnosus hsryfm 1301-containing
skim milk suspension was prepared by suspending the
cells in 10% (w/v) sterile skim milk to achieve a viable
count of 109 CFU/mL, which was then stored at 4°C. Ten-
fold serial dilutions of the suspension were performed,
and 100 μL were plated on MRS agar (pH 6.8 ± 0.2) in
triplicate. Aerobic plates were placed in an anaerobic jar
(Ruskinn Technologies, Ltd.) at 37°C for 48 h. The col-
onies counted after incubation represented the numbers
of L. rhamnosus hsryfm 1301.Preparation of fermented milk
L. rhamnosus hsryfm 1301 was added to 10% heated
skim milk to a final concentration of 3% (v/v) inoculum,
and fermented at 42°C until the milk curdled. Fermenta-
tion was stopped when the bacterial viable count was109 CFU/mL by bacterial counting as above. The fer-
mented milk was stored at 4°C.
Animal trial
Animal groups and diets
Thirty-eight male Sprague–Dawley (SD) rats, aged 5 weeks
and weighing 140 ± 4.5 g were purchased from Comparing
Medical Center of Yang Zhou University (Jiangsu, China).
The rats were exposed to a 12 h light/ dark cycle, and
maintained at a constant temperature of 23 ± 1°C and hu-
midity of 50 ± 5%. The care and use of rats was according
to our institutional and national guidelines, and all experi-
ments were approved by the Ethics Committee of the
Yang Zhou University.
The rats were subjected to a 1-week adaptation period
on a normal diet containing 20% (w/w) flour, 10% rice
flour, 20% corn, 26% drum head, 20% bean, 2% fish
powder and 2% bone powder (XieTong, Organism Inc.,
Jiangsu, China), The rats were randomly assigned to four
groups, control and model group (11 rats each), and two
treatment groups (eight rats each). The initial average
body weight was similar among the four groups. The
four groups were given the following diets: (1) control
group, normal diet; (2) model group, high-fat diet; (3)
hsryfm 1301 group, high-fat diet + L. rhamnosus hsryfm
1301-containing skim milk suspension; (4) hsryfm 1301-f
group, high-fat diet + L. rhamnosus hsryfm 1301-containing
skim fermented milk. The high-fat diet contained 10%
(w/w) lard oil, 1% cholesterol, 0.2% sodium cholate and
78.8% normal diet (XieTong, Organism Inc.). The rats
had free access to water and their specific diet. The
hyperlipidemic rat model was established by providing a
high-fat diet for 28 d. The hsryfm 1301 group and hsryfm
1301-f group received daily 2 mL (109 CFU/mL) of L.
rhamnosus hsryfm 1301-containing skim milk suspension
and L. rhamnosus hsryfm 1301-containing skim fermented
milk, respectively, which was administered intragastrically
for 28 d, after the hyperlipidemic rat model was established
The control and model groups received an equivalent vol-
ume of saline. Their body weight and food consumption
were measured weekly and daily, respectively.
Sample collection
Three fresh fecal samples of 1.00 g (wet weight) were
collected from each group on day 1, 28, and 56 before
feeding. Samples were suspended in 15.0 mL of 0.10 mol/L
phosphate buffer (pH 7.4) by vortexing for 5 min, followed
by addition of 10.0 mL of phosphate buffer and vortexing
for 5 min. This procedure was repeated, and then samples
were centrifugated at 200 × g for 5 min to collect the
supernatant (bacteria). The fecal samples were dealt with
twice as above to collect the supernatant. The supernatant
was centrifuged at 9000 × g for 5 min, and then the pel-
let was suspended in 30.0 mL of phosphate buffer by
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The sediment was collected and suspended in 10 mL of
0.10 mol/L phosphate buffer (pH 7.4) by vortexing for
5 min, aliquoted into five tubes, and kept at −70°C for
DNA extraction.
Three rats, which were fasted for 12 h and euthanized,
were selected randomly from the control and model
group at day 28. Blood samples (4 mL) were collected
into nonheparinized vacuum collection tubes from the
celiac vein. Tubes were initially held stationary at 0°C
for 30 min, and then the serum was separated from the
blood by centrifugation at 2, 000 × g for 10 min at 4°C,
and was used to analyze the lipids’ level.Serum lipids analysis
Triglycerides (TG), total cholesterol (TC), high density
lipoprotein cholesterol (HDL-C) and low density lipo-
protein cholesterol (LDL-C) in the serum were analyzed
by commercial kits (Maker, Biotechnology Inc., Sichuan,
China) and the chemical analyzer 7020 (Hitachi, Tokyo,
Japan). After administering the treatment intragastrically
for 28 d, all rats were weighed and the TC, TG, HDL-C and





























Figure 1 Serum lipid levels of the control and model groups at
28 d. Control group: normal diet; model group: high-fat diet. Each
concentration is the mean ± standard deviation (n = 3). *, P < 0.05
vs. control.Gut microbiota analysis
Microbial DNA from the fecal samples was extracted
using QIAamp DNA stool mini kit (Qiagen Inc., Hilden,
Germany) according to the manufacturer’s instructions.
The V3 hypervariable region of the 16S rDNA was PCR
amplified from the microbial genomic DNA using universal
primer (forward primers: 5′-ACTCCTACGGGAGGCAG
CAG-3′, reverse primers:
5′- TTACCGCGGCTGCTGGCAC-3′). The PCR con-
dition were 94°C for 4 min, followed by 21 cycles of 94°C
for 30 s, 58°C for 30 s (annealing) and 72°C for 30 s
(extension), and then 72°C for 5 min.
The PCR products were excised from a 1.5% agarose gel
and purified by AxyPrep Gel Extraction Kit (Axygen, Sci-
entific Inc., Union City, CA, USA). They were then quan-
tified by PicoGreen dsDNA Assay Kit (Life Technologies
Inc., Grand Island, NY, USA) and BioTek Microplate
Reader (BioTek Inc., Winooski, VT, USA). The Barcoded
V3 amplicon was sequenced using the pair-end method
by Illumina Miseq at Personal Biotechnology Co., Ltd
(Shanghai, China). Sequences reads with an average
quality score lower than 25, ambiguous bases, homopol-
ymer > 7 bases, containing primer mismatches, or reads
length shorter than 100 bp were removed. For V3 pair-
end read, only sequences that overlapped more than
10 bp and without any mismatches were assembled [15].
Reads that could not be assembled were removed. Bar-
code and sequencing primers were trimmed from as-
sembled sequences.Statistical analysis
The SPSS software (IBM Corp, Armonk, NY, USA) was
used to analyze the serum lipids data and the association
between serum lipids and intestinal microbiota.
Sequences were clustered and assigned to operational
taxonomic units (OTUs) using the Quantitative Insights
into Microbial Ecology (QIIME) implementation of cd-
hit according to a threshold of 97% pairwise identity.
The OTU of every sample and the number of sequences
of every OTU were counted after the OTU output. The
taxonomy information of every OTU was obtained by
searching the most similar species. The rarefaction curve
was generated by OTUs at the 97% similarity cut-off
level. Rarefaction analysis was performed in Analytic
Rarefaction v.1.3 (Hunt Mountain Software, Athens, GA,
USA). The Chao1 and ACE abundance indexes, and the
Simpson and Shannon diversity indexes were calcu-
lated using Mothur software (http://www.mothur.org/)
to analyze Alpha diversity. The SPSS (IBM Corp), Fast
UniFrac (http://bmf2.colorado.edu/fastunifrac/) and QIIME
(http://qiime.sourceforge.net/) software were used to
analyze sequence data, bacterial community distribution
and the principal component.
Results
Effects of L. rhamnosus hsryfm 1301 and its fermented
milk on physical indexes of a hyperlipidemic rat model
The rats in the control and model groups were fed with
normal diet or high-fat diet for 28 d, respectively. The
serum lipids’ levels are summarized in Figure 1. The TC
and TG levels in the model group were significantly
higher than those in the control group (P < 0.05; Figure 1),
indicating that the hyperlipidemia rat model was success-
fully established. The HDL-C and LDL-C levels in the
control group were lower than those in the model group,
but not significantly (P > 0.05; Figure 1).
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period. At the end of the experiment, the gained body
weight and the average food consumption of the model
group were significantly higher than those of the other
groups (P < 0.05; Figure 2A and B). The efficiency of diet
utilization of the hsryfm 1301-f group was significantly
higher than that of the control and model groups (P < 0.05;
Figure 2C), indicating that the L. rhamnosus hsryfm fer-
mented milk improved the efficiency of diet utilization.
After the rats were administered intragastrically L.
rhamnosus hsryfm 1301 or its fermented milk for 28 d,
the TC, TG and HDL-C levels in the control, hsryfm
1301 and hsryfm 1301-f groups were significantly lower
than those in the model group (P < 0.05; Figure 2D).
Also, the LDL-C level in the hsryfm 1301-f group was
significantly lower than that in the model group (P < 0.05;
Figure 2D). The results indicate that L.rhamnosus hsryfm
1301 and its fermented milk had obvious effects on rat
serum lipids.
Effects of L. rhamnosus hsryfm 1301 and its fermented
milk on rats intestinal microbiota
Sequencing results of fecal samples
In total, 87,228 sequence reads were obtained and
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Treatment
Figure 2 Physical indexes of rats. Control group: normal diet; model grou
1301-containing skim milk suspension; hsryfm 1301-f group: high-fat diet + L.
of the rats in 56 d; B: Food consumption of the rats in 56 d; C: Efficiency of di
in the rats. Efficiency of diet utilization (%) = (Weight gain/Food consumption
superscript letters means significant difference in the same index (P < 0.05).level. Among the high quality sequences, more than 95%
were longer than 146 bp, with most ranging between
146 and 177 bp. The number of OTUs of Phylum, Class,
Order, Family and Genus detected by sequencing was
5,359, 4,348, 4,140, 2,583 and 2,583, respectively.
Rarefaction analysis showed that the OTUs of 36 sam-
ples gradually increased with the increase of the number
of measured sequences. Furthermore, the curve became
more gentle and the increasing trend became smaller
(see Additional file 1: Figure S1), indicating that most of
the bacterial sequences in the samples obtained by the
Illumina Miseq Sequencing system reflected the abun-
dance and diversity of the gut microbiota.
Analysis of alpha diversity of gut microbiota
The Chao1, ACE and Shannon indexes were significantly
higher and the Simpson index was significantly lower at
1 d compared with after feeding high-fat diet for 28 d or
normal diet for 56 d (P < 0.05; Table 1), indicating that
the abundance and diversity of the gut microbiota in rats
decreased with the weight increase. However, the abun-
dance and diversity recovered or was even higher than
the initial level after rats were administered intragastri-
cally L. rhamnosus hsryfm 1301 or its fermented milk






































































hsryfm 1301 hsryfm 1301-f
Treatment
Control Model
hsryfm 1301 hsryfm 1301-f
Treatment
p: high-fat diet; hsryfm 1301 group: high-fat diet + L. rhamnosus hsryfm
rhamnosus hsryfm 1301-containing skim fermented milk. A: Weight gain
et utilization of the rats; D: Serum TC, TG, HDL-C and LDL-C concentration
) × 100. Each value is the mean ± standard deviation (n = 8). A different




Abundance index Diversity index
Chao1 ACE Simpson Shannon
Control 1 16332.081a 23580.922a 0.067b 15.876a
28 16957.731a 23883.323a 0.072b 15.705a
56 14196.252b 21689.237b 0.088a 15.460b
Model 1 13796.613a 19983.587a 0.063c 15.864a
28 12538.624b 18339.896b 0.075b 15.221b
56 11200.145c 18168.955b 0.103a 14.828c
Hsryfm 1301 1 14699.544a 21791.684b 0.075b 15.531a
28 12836.493b 19663.483c 0.096a 14.763b
56 14947.348a 22180.152a 0.077b 15.455a
Hsryfm 1301-f 1 14725.082a 21799.783b 0.067b 15.740a
28 13664.791b 20176.062c 0.073a 15.406b
56 14982.826a 22405.761a 0.068b 15.723a
The Chao1, ACE, Simpson and Shannon indexes are presented for a similarity of 0.97 between the reads. Values of the same group within a column with different
superscript letters mean the index differ significantly at different time points (P < 0.05, n =3).
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the gut microbiota in rats, while the L. rhamnosus
hsryfm 1301 or its fermented milk improved them.
Principal component analysis of the gut microbiota
The sequences of 36 fecal samples from 1, 28 and 56 d
were used for principal component analysis. The similarity
between microbiota can be expressed by the BeTa diversity
analysis using the unweighted UniFrac and QIIME pro-
cedure. Each point represents one sample’s microbiota,
and the distance between points represents the similarity
between sequences of two samples’ microbiota.
We found that the gut microbiota at the three tested
time points were separated from each other, except for
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Figure 3 Relative abundance of the gut microbiota in rats at the phy
group: high-fat diet; hsryfm 1301 group: high-fat diet + L. rhamnosus hsryfm
diet + L. rhamnosus hsryfm 1301-containing skim fermented milk.gathered together at the same time point (see Additional
file 2: Figure S2), showing that the gut microbiota in rats
was significantly different at the different time points
and treatments. The gut microbiota in the control group
at 28 d was not separated from the 1 d microbiota, indi-
cating that the normal diet did not affect the gut micro-
biota at 28 d, and the abundance and diversity of the gut
microbiota had not changed significantly (Table 1).
Composition of the gut microbiota
The gut microbiota of the rats was constituted of Bac-
teroidetes, Firmicutes, Proteobacteria, Spirochaetes and
Verrucomicrobia at the phylum level, and the Bacteroi-
detes were the most abundant, followed by Firmicutes










fm 1301 hsryfm 1301-f
28 56 1 28 56
lum level at different time points. Control group: normal diet; model
1301-containing skim milk suspension; hsryfm 1301-f group: high-fat
Chen et al. BMC Complementary and Alternative Medicine 2014, 14:386 Page 6 of 9
http://www.biomedcentral.com/1472-6882/14/386or high-fat diet for 56 d, the relative abundance of Bacter-
oidetes and Verrucomicrobia in the rats’ gut significantly
decreased (P < 0.05) and of Firmicutes significantly in-
creased (P < 0.05; Table 2). Except for Bacteroidetes,
opposite results were observed after treatment with L.
rhamnosus hsryfm 1301 or its fermented milk for 28 d
(P < 0.05; Table 2). The relative abundance of Spirochaetes
in the control, hsryfm 1301 and hsryfm 1301-f groups
significantly increased, whereas it significantly decreased
in the model group at 56 d compared with that at 1 d
(P < 0.05; Table 2).Table 2 Difference in abundance of intestinal microbiota in ra
Relative abund
1 d
Taxon Control Model hsryfm 1301 hsryfm
Actinobacteria 0.10 ± 0.01 0.17 ± 0.02 0.20 ± 0.01 0.13 ±
Collinsella 0.00 ± 0.00 0.10 ± 0.01 0.10 ± 0.01 0.06 ±
Bacteroidetes 44.00 ± 2.50 46.80 ± 1.56 44.40 ± 2.12 39.10 ±
Bacteroides 1.47 ± 0.21 2.43 ± 0.12 2.33 ± 0.15 1.93 ±
Barnesiella 0.10 ± 0.01 0.07 ± 0.01 0.08 ± 0.02 0.08 ±
Parabacteroides 0.30 ± 0.02 0.47 ± 0.03 0.40 ± 0.02 0.33 ±
Alistipes 0.30 ± 0.02 0.10 ± 0.01 0.10 ± 0.01 0.13 ±
Prevotella 20.47 ± 1.02 22.77 ± 1.13 18.93 ± 1.08 17.67 ±
Deferribacteres 0.10 ± 0.01 0.10 ± 0.02 0.10 ± 0.01 0.10 ±
Mucispirillum 0.10 ± 0.01 0.10 ± 0.02 0.10 ± 0.01 0.10 ±
Firmicutes 31.80 ± 2.05 25.83 ± 1.53 28.20 ± 1.74 32.90 ±
Lactobacillus 0.10 ± 0.02 0.10 ± 0.01 0.10 ± 0.01 0.10 ±
Butyrivibrio 0.13 ± 0.01 0.15 ± 0.01 0.07 ± 0.01 0.10 ±
Dorea 0.13 ± 0.02 0.14 ± 0.01 0.17 ± 0.02 0.17 ±
Enterococcus 0.10 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.10 ±
Oscillibacter 1.63 ± 0.14 1.60 ± 0.11 2.07 ± 0.16 2.60 ±
Ruminococcus 0.30 ± 0.02 0.10 ± 0.01 0.20 ± 0.01 0.20 ±
Allobaculum 0.20 ± 0.01 0.27 ± 0.02 0.20 ± 0.01 0.20 ±
Acetanaerobacterium 0.00 ± 0.00 0.00 ± 0.00 0.07 ± 0.01 0.00 ±
Holdemania 0.00 ± 0.00 0.07 ± 0.01 0.00 ± 0.00 0.00 ±
Proteobacteria 5.50 ± 1.05 8.03 ± 1.62 7.43 ± 1.16 10.00 ±
Campylobacter 0.13 ± 0.01 0.13 ± 0.02 0.10 ± 0.01 0.10 ±
Helicobacter 0.97 ± 0.12 1.17 ± 0.19 0.77 ± 0.05 2.40 ±
Escherichia/Shigella 0.13 ± 0.01 0.10 ± 0.01 0.07 ± 0.01 0.13 ±
Spirochaetes 0.20 ± 0.02 0.43 ± 0.03 0.43 ± 0.02 0.33 ±
Treponema 0.20 ± 0.01 0.43 ± 0.03 0.43 ± 0.02 0.33 ±
Verrucomicrobia 4.30 ± 0.32 4.53 ± 0.36 4.50 ± 0.38 2.17 ±
Akkermansia 4.23 ± 0.30 4.50 ± 0.35 4.50 ± 0.38 2.13 ±
TM7 0.10 ± 0.01 0.00 ± 0.00 0.00 ± 0.00 0.10 ±
Other 13.90 ± 1.35 14.03 ± 1.42 14.77 ± 1.51 15.13 ±
Each value is the mean ± standard deviation (n = 3). Data were analyzed using one-
Duncan test. *means values in the same row of 56 d are significantly different fromBacteroides spp., Prevotella spp., Oscillibacter spp.,
Helicobacter spp. and Akkermansia spp. were the pri-
mary intestinal microbiota in the rats’ gut at the genus
level (Table 2). The relative abundance of 22 genera of
the intestinal microbiota belonging to Actinobacteria,
Bacteroidetes, Deferribacteres, Firmicutes, Proteobacteria,
Spirochaetes and Verrucomicrobia was significantly differ-
ent after being fed a high-fat diet for 56 d and adminis-
tered intragastrically L. rhamnosus hsryfm 1301 or its
fermented milk for 28 d (P < 0.05; Table 2). The serum
lipids in the control, hsryfm 1301 and hsryfm 1301-fts
ance (percent of total sequences)
56 d
1301-f Control Model hsryfm 1301 hsryfm 1301-f
0.01 0.27 ± 0.01 0.17 ± 0.02 0.13 ± 0.01 0.13 ± 0.01
0.01 0.17 ± 0.02* 0.09 ± 0.001 0.10 ± 0.01 0.10 ± 0.01**
1.20 27.63 ± 1.53** 35.03 ± 1.20** 45.50 ± 2.62 40.33 ± 1.72
0.20 1.10 ± 0.16 1.40 ± 0.11* 4.50 ± 0.26** 3.33 ± 0.28**
0.01 0.17 ± 0.01 0.10 ± 0.01 0.00 ± 0.00* 0.00 ± 0.00*
0.01 0.20 ± 0.01 0.30 ± 0.02* 0.45 ± 0.01* 0.40 ± 0.01
0.01 0.10 ± 0.01* 0.17 ± 0.01* 0.05 ± 0.01* 0.13 ± 0.01
1.12 16.10 ± 2.03* 14.83 ± 1.16** 21.03 ± 1.15* 17.57 ± 1.09
0.01 0.20 ± 0.01* 0.10 ± 0.01 0.10 ± 0.02 0.17 ± 0.02*
0.01 0.13 ± 0.01 0.10 ± 0.01 0.10 ± 0.02 0.17 ± 0.02*
1.85 41.80 ± 2.05* 37.03 ± 1.64* 23.23 ± 1.26* 27.57 ± 1.02*
0.02 0.12 ± 0.01 0.10 ± 0.02 0.17 ± 0.01* 0.27 ± 0.02*
0.01 0.15 ± 0.01 0.10 ± 0.01 0.20 ± 0.02* 0.27 ± 0.02**
0.02 0.09 ± 0.01 0.23 ± 0.01* 0.12 ± 0.01* 0.10 ± 0.01*
0.01 0.15 ± 0.01* 0.37 ± 0.01** 0.05 ± 0.01* 0.06 ± 0.01*
0.21 2.33 ± 0.18* 3.37 ± 0.31** 1.43 ± 0.13* 1.83 ± 0.18*
0.01 0.57 ± 0.04** 0.37 ± 0.04** 0.16 ± 0.02* 0.17 ± 0.02*
0.01 0.24 ± 0.02 0.10 ± 0.01* 0.47 ± 0.03** 0.27 ± 0.02
0.00 0.10 ± 0.01* 0.00 ± 0.00 0.10 ± 0.01 0.03 ± 0.001*
0.00 0.00 ± 0.00 0.00 ± 0.00* 0.10 ± 0.01* 0.03 ± 0.01*
1.78 6.40 ± 0.76 6.80 ± 0.85 9.67 ± 1.13 12.30 ± 1.19
0.01 0.11 ± 0.01 0.12 ± 0.01 0.00 ± 0.00* 0.00 ± 0.00*
0.19 1.27 ± 0.22 1.20 ± 0.15 1.13 ± 0.21 1.27 ± 0.16*
0.01 0.10 ± 0.002 0.07 ± 0.01 0.00 ± 0.00* 0.03 ± 0.001*
0.02 0.60 ± 0.03** 0.30 ± 0.02* 0.63 ± 0.04* 0.50 ± 0.02*
0.02 0.40 ± 0.04** 0.30 ± 0.02* 0.60 ± 0.03* 0.50 ± 0.04*
0.23 2.63 ± 0.31* 2.00 ± 0.18** 5.73 ± 0.51* 3.73 ± 0.32*
0.21 2.60 ± 0.29* 2.00 ± 0.18** 5.73 ± 0.51* 3.70 ± 0.25*
0.01 0.10 ± 0.01 0.10 ± 0.01* 0.00 ± 0.00 0.00 ± 0.00*
1.47 20.40 ± 2.14* 18.47 ± 1.78 14.90 ± 1.65 16.20 ± 1.55
way ANOVA. Differences between treatment periods were assessed by the
those of 1 d (P < 0.05); **, P < 0.01.
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model group at 56 d (P < 0.05; Figure 2D).
L. rhamnosus hsryfm 1301 and its fermented milk sig-
nificantly decreased the relative abundance of Barnesiella
spp., Dorea spp., Enterococcus spp., Oscillibacter spp.,
Ruminococcus spp., Campylobacter spp. and Escherichia/
Shigella spp. (P < 0.05), while they significantly increased
the relative abundance of Bacteroides spp., Lactobacillus
spp., Butyrivibrio spp., Holdemania spp., Treponema spp.
and Akkermansia spp. (P < 0.05; Table 2). L. rhamnosus
hsryfm 1301 significantly increased the relative abundance
of Parabacteroides spp., Prevotella spp., Allobaculum spp.
and Psychrobacter spp. (P < 0.05), while it significantly de-
creased that of Alistipes spp. (P < 0.05; Table 2). L. rham-
nosus hsryfm 1301 fermented milk significantly increased
the relative abundance of Collinsella spp., Mucispirillum
spp. and Acetanaerobacterium spp. (P < 0.05), while it sig-
nificantly decreased the relative abundance of Helicobacter
spp. (P < 0.05; Table 2).
Discussion
Recently, it has been reported that the host intestinal
microbiota depends not only on hereditary factors, but
also on environmental factors including age, diet and liv-
ing environment [16]. Diet intervention is controllable,
and can improve the intestinal microbiota for the long-
term and induce beneficial changes [17]. Our findings
provide evidence for an important modification of the
intestine resulting from a probiotic treatment, and indi-
cate its contribution to improvement of host serum lipids.
Secondary bile acid, hydrogen sulfide and other harm-
ful products are produced in rats during lipid metabol-
ism after a high-fat diet intervention, which harm the
colorectal mucosa and damage the micro environment
of the intestine that helps bacteria survive [18,19]. Con-
sistently, we showed that high-fat diet decreased the abun-
dance and diversity of the intestinal microbiota in rats,
and that the abundance of Bacteroidetes and Firmicutes
decreased and increased, respectively, in rats’ gut. How-
ever, some polysaccharides, bile acid and steroids in the
diet could be absorbed and metabolized by Bacteroidetes,Table 3 Associations between serum lipids and intestinal mic
TC LDL HDL Dorea spp.
TG 0.745 0.65 0.349 −0.305






The SPSS Pearson analysis was used to calculate the Pearson’s correlation coefficien
lipids of rats at 56 d (n = 3).which the host cannot metabolize [20], and the calories in
the food could be absorbed by Firmicutes, which pro-
motes fat storage in the host body [21]. The relative abun-
dance of Akkermansia spp. also decreased after a high-fat
diet, which is consistent with Everard et al. [22]. Akker-
mansia spp. can improve the gastrointestinal mucosal
barrier by increasing the rat gastrointestinal mucus layer
thickness, and thus prevent some harmful substances
from passing through the intestine into the blood, fore-
stall fat mass storage in vivo and ameliorate high serum
lipid-related metabolic diseases caused by obesity [22].
Lactic acid bacteria can compete for intestinal nutri-
ents, and occupy some adsorption sites and metabolites
to improve the intestinal environment in rats [23,24].
Consistent with Xie et al. [25], the harmful bacteria
Escherichia/Shigella spp. and the probiotic Lactobacillus
spp. were suppressed and promoted, respectively, in the
rats’ gut after administering intragastrically L.rhamnosus
hsryfm 1301 or its fermented milk for 28 d. The rats’
serum lipids and efficiency of diet utilization improved
by L. rhamnosus hsryfm 1301 or its fermented milk, which
also recovered the abundance and diversity of the intes-
tinal microbiota, which showed increased and decreased
abundance of Bacteroidetes and Firmicutes, respectively.
The short chain fatty acids produced by the recovered in-
testinal microflora reduced the TG and TC level by inhi-
biting the hepatic lipogenic enzyme activity and regulating
the cholesterol distribution in the blood and liver [26,27].
Accordingly, L. rhamnosus hsryfm 1301 and its fermen-
tation products kept the balance of intestinal microbiota
in rats, to alleviate the adverse effects induced by a
high-fat diet.
Significant differences were observed in 22 genera of
intestinal bacteria in the hsryfm 1301 and its fermented
milk groups (Table 2). In fermented milk, not only the
Lactobacillus itself, but also the fermentation products
can have probiotic effects on the intestinal microbiota
[28]. Recently, a study has shown that fermented milk
could increase the number of cells with cytokines, which
reduce cell death and enhance the function of the thy-
mus to improve the mucosa and immune system of therobiota








t (r). *, P < 0.05. The sample sequencing of rats corresponds with the serum
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hand, the fermented milk could improve the expression
of the microbiome, which participates in lipid and carbo-
hydrate metabolism [29]. The TC and LDL-C levels in
the hsryfm 1301-f group were lower than those in the
hsryfm 1301 group, possibly because the L. rhamnosus
hsryfm 1301 fermented milk could enhance the expres-
sion of bacteria that improve lipid metabolism, such as
Butyrivibrio spp. (Table 2).
Analysis of the association between intestinal microbiota
and serum lipids at 56 d showed a positive correlation
between bacteria related to Ruminococcus spp. and TG,
Dorea spp. and TC and LDL-C, and between Enterococcus
spp. and HDL-C. The positive correlation between Rumi-
nococcus spp. and Dorea spp., which belong to Clostrid-
ium, and serum lipids (P < 0.05; Table 3), is consistent
with the findings by Lahti et al. [30], who found that
Ruminococcus spp. was enriched by polyunsaturated and
odd-chain fatty acids, which are not synthesized in the
body, and that Ruminococcus spp. facilitates the absorp-
tion of polyunsaturated dietary lipids. The bacteria related
to Butyrivibrio spp. negatively correlated with TC and
LDL-C (P < 0.05; Table 3), and Butyrivibrio spp. has the
c9, tll activity of linoleate isomerase [31], which could de-
crease the mRNA expression of SREBP-1c [32]. Sterol
regulatory element-binding protein (SREBP)-1c is one
of the important elements that adjusts lipid metabolism
[33,34], thus the increase in abundance of Butyrivibrio
spp. could lower the lipid levels in rats.
Conclusions
We suggest that the intestinal microbiota and serum
lipids in rats improved by feeding L. rhamnosus hsryfm
1301 or its fermented milk for 28 d. The correlation be-
tween serum lipids and Ruminococcus spp., Dorea spp.
and Enterococcus spp. was positive (P < 0.05), while the
correlation between Butyrivibrio spp. and serum lipids
was negative (P < 0.05). We believe that long-term con-
tinuous monitoring of changes in intestinal microbiota
will provide further insight into the role of intestinal
microbiota in human lipid metabolism.
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